Analyzing Cost of Revenue: Walgreens Boots Alliance, Inc. and Perrigo Company plc

Cost of Revenue Trends: Walgreens vs. Perrigo

__timestampPerrigo Company plcWalgreens Boots Alliance, Inc.
Wednesday, January 1, 2014261310000054823000000
Thursday, January 1, 2015289150000076691000000
Friday, January 1, 2016322880000087477000000
Sunday, January 1, 2017296670000089052000000
Monday, January 1, 20182900200000100745000000
Tuesday, January 1, 2019306410000091915000000
Wednesday, January 1, 2020324810000095905000000
Friday, January 1, 20212722500000104442000000
Saturday, January 1, 20222996200000104437000000
Sunday, January 1, 20232975200000112009000000
Monday, January 1, 2024121134000000
Loading chart...

In pursuit of knowledge

Analyzing Cost of Revenue: Walgreens Boots Alliance vs. Perrigo

In the ever-evolving landscape of the pharmaceutical industry, understanding cost dynamics is crucial. From 2014 to 2023, Walgreens Boots Alliance, Inc. consistently outpaced Perrigo Company plc in terms of cost of revenue. Walgreens' cost of revenue surged by approximately 104% over this period, peaking at an impressive $112 billion in 2023. In contrast, Perrigo's cost of revenue remained relatively stable, fluctuating around $3 billion annually, with a slight increase of about 14% over the same period.

This disparity highlights Walgreens' expansive operations and market reach compared to Perrigo's more focused approach. The data for 2024 is incomplete, but Walgreens' trajectory suggests continued growth. Investors and industry analysts should consider these trends when evaluating the financial health and strategic positioning of these companies.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025